14 Jun 2017 | Infection Prevention & Control
The Commission is seeking interested participants from surgical providers to develop a standardised national pre-operative anti-staphylococcal bundle (the bundle). The bundle will include components of pre-operative interventions to support a reduction in surgical site infections (SSI) caused by Staphylococcus aureus (S. aureus), and will be developed using collaborative methodologies between August 2017 and June 2018.
A letter has been sent to district health board chief executives; chief medical officers, and directors of nursing seeking interested participants. It has also been sent to the New Zealand Private Surgical Hospitals Association.
In New Zealand, data is collected on all SSIs occurring as a result of hip and knee arthroplasty and cardiac procedures in DHBs. Review of this data reveals that approximately 30 percent of SSIs resulting from these particular procedures are due to S. aureus. While there is consistently high compliance in a number of process measures nationally, there is opportunity to reduce the risk of SSI in patients that are colonised with S. aureus by implementing a specific bundle of interventions pre-operatively and in doing so reduce costs and create more consistent best practice across New Zealand.
We aim to reduce the staph SSI rate by 20 percent by 30 June 2019 for providers who are participating in the collaborative. Participants will be able to select whether they wish to test the bundle for the cardiac and/or orthopaedic pathways, as we know that we have existing data systems for these procedures. Over time, however, this can be expanded into other clinical pathways.
The closing date for submitting an application of interest is 23 June 2017 by 5pm. If you are interested it is recommended that you discuss with your chief executive or other senior leadership team, and SSII Champions/IPC Committees regarding the opportunity for joining this collaborative.